Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

Description

Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

Conditions

Cardiac Transplant Disorder

Study Overview

Study Details

Study overview

Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation, a Multicenter Study (INTERHEART)

Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

Condition
Cardiac Transplant Disorder
Intervention / Treatment

-

Contacts and Locations

Los Angeles

UCLA Medical Centre, Los Angeles, California, United States, 90024

Los Angeles

Cedars-Sinai Heart Institute, Los Angeles, California, United States, 90048

Dallas

Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute, Dallas, Texas, United States, 75246

Salt Lake City

Cardiovascular Medicine, University of Utah Health, Salt Lake City, Utah, United States, 84132

Richmond

Virginia Commonwealth University, Division of Cardiology, Richmond, Virginia, United States, 23298

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * biopsy for clinical indications
  • * no consent
  • * pregnant women

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Alberta,

Philip F Halloran, MD PhD, PRINCIPAL_INVESTIGATOR, University of Alberta

Study Record Dates

2026-07